Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06118346 · ClinicalTrials.gov registry record · NA
A Female-Specific CBT Group for Veteran Women With Alcohol Use Disorder in VA Primary Care Settings
A NA study of Alcohol Use Disorder and Risky Health Behavior, sponsored by University of Massachusetts, Worcester.
- Recruiting
- Registry status
- NA
- Development phase
- 162
- Enrollment target
- 1
- Study location
NCT06118346: Recruiting NA study of Alcohol Use Disorder and Risky Health Behavior, sponsored by University of Massachusetts, Worcester.
NCT06118346 is a NA study of Alcohol Use Disorder and Risky Health Behavior that is actively recruiting participants, run by University of Massachusetts, Worcester. The registered enrollment target is 162 participants, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06118346, a NA study of Alcohol Use Disorder and Risky Health Behavior, is actively recruiting participants, sponsored by University of Massachusetts, Worcester.
- RECRUITING
- Registry status
- NA
- Development phase
- 162 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate a Female-Specific Cognitive Behavioral Therapy (CBT) Group as treatment for Alcohol Use Disorder among Veteran women.
Primary Outcome
10-item screening tool to assess alcohol consumption, drinking behaviors, and alcohol-related problems
Conditions Studied
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL Female-Specific Cognitive Behavioral Therapy (FS-CBT)
Study Locations (1)
New York
- VA New York Harbor Healthcare System - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 162 participants |
| Start Date | 2023-02-24 |
| Est. Completion | 2027-01-30 |
| Phase | NA |
What NCT06118346 shows while recruiting
NCT06118346 is an interventional study that assigns participants to a tested intervention. The registered 162 participants enrollment target is mid-sized for trials with a published cap, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (51% lower).
The record links to 2 conditions, with Alcohol Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.
NCT06118346 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06118346 about?
NCT06118346 is a clinical study titled "A Female-Specific CBT Group for Veteran Women With Alcohol Use Disorder in VA Primary Care Settings". The purpose of this study is to evaluate a Female-Specific Cognitive Behavioral Therapy (CBT) Group as treatment for Alcohol Use Disorder among Veteran women.
What is the current status of trial NCT06118346?
This trial is currently recruiting. It is a NA study. The enrollment target is 162 participants. The study started on 2023-02-24. Estimated completion is 2027-01-30.
What conditions does trial NCT06118346 study?
This clinical trial studies the following conditions: Alcohol Use Disorder, Risky Health Behavior.
What interventions are being tested in trial NCT06118346?
The interventions under investigation include: Usual Care (BEHAVIORAL), Female-Specific Cognitive Behavioral Therapy (FS-CBT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06118346?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06118346 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06118346's enrollment target sits among peer trials
162 57th of 184 higher than 128 of 184 other Alcohol Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcohol Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ultrasound Neuromodulation of the Brain for Alcohol Use Disorder
RECRUITING · NA
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Integrated Treatment for Enhancing Growth in Recovery During Adolescence
RECRUITING · NA
-
AAT for Alcohol Use Disorder in Veterans
RECRUITING · NA
-
Testing a PTSD m-Health Intervention to Improve Alcohol Treatment Outcomes
RECRUITING · NA
-
Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral Therapy for Comorbidity
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02347111 · 162 participants · Phase 4
Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation
- NCT02610426 · 162 participants
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer
- NCT05040711 · 162 participants · NA
mHealth Mindfulness With Patients With Serious Illness and Their Caregivers
- NCT05514717 · 162 participants · Phase 1
A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI